Metformin Improves Fertility in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review
Abstract
Abstract: Polycystic ovary syndrome (PCOS) Causes 6-15% of female infertility, of which 80% is characterized by the occurrence of hyperinsulinemia resulting in impaired endometrial function. Metformin therapy in improving insulin sensitivity has been widely reported, but investigations are needed to determine the characteristics of metformin therapy research in PCOS cases with a literature review study approach. In the collection of systematic studies, Publish and Perish, Mendeley and Microsoft Excel applications, using the keyword metformin improves fertility in women with PCOS. From 500 articles collected, 16 articles were included in the inclusion criteria, and it was found that many studies had been conducted in several countries (Iran, India, USA, Italy, Egypt, Pakistan and Saudi Arabia involving 2295 subjects, with a dose range of 500 mg to 2000 mg, with a duration of administration of 14 days to 9 months. In this study, it was concluded that metformin intervention studies both singly and in combination clinically have been conducted in several countries where most studies show that metformin can improve clinical and laboratory improvements in PCOS patients, which can improve the fertility rate of women with PCOS.
Keywords
Full Text:
PDFReferences
Shokrpour M, Foroozanfard F, Afshar Ebrahimi F, et al. Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial. Gynecol Endocrinol. 2019;35(5):406-411. doi:10.1080/09513590.2018.1540570
Agrawal A, Mahey R, Kachhawa G, Khadgawat R, Vanamail P, Kriplani A. Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial. Gynecol Endocrinol. 2019;35(6):511-514. doi:10.1080/09513590.2018.1549656
Tauqir S, Israr M, Rauf B, et al. Acetyl-l-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial. Adv Ther. 2021;38(7):3842-3856. doi:10.1007/s12325-021-01789-5
El Sharkwy I, Sharaf El-Din M. l-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial. Gynecol Endocrinol. 2019;35(8):701-705. doi:10.1080/09513590.2019.1576622
Zhai J, Yao GD, Wang JY, et al. Metformin Regulates Key MicroRNAs to Improve Endometrial Receptivity Through Increasing Implantation Marker Gene Expression in Patients with PCOS Undergoing IVF/ICSI. Reprod Sci. 2019;26(11):1439-1448. doi:10.1177/1933719118820466
Foda AA, Foda EA, El-Negeri MA, El-Said ZH. Serum chemerin levels in Polycystic Ovary Syndrome after metformin therapy. Diabetes Metab Syndr Clin Res Rev. 2019;13(2):1309-1315. doi:10.1016/j.dsx.2019.01.050
Zheng S, Liu E, Zhang Y, et al. Circulating zinc-α2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment. Endocr J. 2019;66(6):555-562. doi:10.1507/endocrj.EJ18-0153
Liu Y, Li J, Yan Z, Liu D, Ma J, Tong N. Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review. Front Endocrinol (Lausanne). 2021;12. doi:10.3389/fendo.2021.657889
Mohamed S. Can Insulin Sensitizer Drugs Enhance the Result of Assisted Reproductive Cycles when Used for PCOS Women Undergoing ART? Meta-Analysis and …. EC Gynaecol. Published online 2022. https://ecronicon.org/assets/ecgy/pdf/ECGY-11-00728.pdf
Cabrera-Cruz H, Oróstica L, Plaza-Parrochia F, Torres-Pinto I, Romero C, Vega M. The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment. Am J Physiol - Endocrinol Metab. 2020;318(2):E237-E248. doi:10.1152/ajpendo.00162.2019
Soldat-Stanković V, Popović-Pejičić S, Stanković S, et al. The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. J Endocrinol Invest. 2022;45(3):583-595. doi:10.1007/s40618-021-01691-5
Sohrevardi SM, Heydari B, Azarpazhooh MR, et al. Therapeutic Effect of Curcumin in Women with Polycystic Ovary Syndrome Receiving Metformin: A Randomized Controlled Trial. Adv Exp Med Biol. 2021;1308:109-117. doi:10.1007/978-3-030-64872-5_9
Chang HH, Hsueh YS, Cheng YW, Ou HT, Wu MH. Association between polymorphisms of OCT1 and metabolic response to metformin in women with polycystic ovary syndrome. Int J Mol Sci. 2019;20(7). doi:10.3390/ijms20071720
Abdalmageed OS, Farghaly TA, Abdelaleem AA, Abdelmagied AE, Ali MK, Abbas AM. Impact of Metformin on IVF Outcomes in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Controlled Trial. Reprod Sci. 2019;26(10):1336-1342. doi:10.1177/1933719118765985
Ali DES, Shah M, Ali A, et al. Treatment with Metformin and Combination of Metformin plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial. Horm Metab Res. 2019;51(11):714-722. doi:10.1055/a-1018-9606
Acosta-Torres S, Murdock T, Matsuno R, et al. The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates. Gynecol Oncol. 2020;157(2):348-356. doi:10.1016/j.ygyno.2020.02.008
Erensoy H, Niafar M, Ghafarzadeh S, Aghamohammadzadeh N, Nader ND. A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(1):72-75. doi:10.1080/09513590.2018.1498476
Alhussain F, Alruthia Y, Al-Mandeel H, et al. Metformin improves the depression symptoms of women with polycystic ovary syndrome in a lifestyle modification program. Patient Prefer Adherence. 2020;14:737-746. doi:10.2147/PPA.S244273
Sahu A, Tripathy P, Mohanty J, Nagy A. Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial. J Gynecol Obstet Hum Reprod. 2019;48(5):335-339. doi:10.1016/j.jogoh.2018.10.006
Pourghasem S, Bazarganipour F, Taghavi SA, Kutenaee MA. The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole. Arch Gynecol Obstet. Published online 2019. doi:10.1007/s00404-019-05064-5
Andræ F, Abbott D, Stridsklev S, et al. Sustained maternal hyperandrogenism during pcos pregnancy reduced by metformin in non-obese women carrying a male fetus. J Clin Endocrinol Metab. 2020;105(12):3762-3770. doi:10.1210/clinem/dgaa605
Xing C, Li C, He B. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women with PCOS. J Clin Endocrinol Metab. 2020;1051. Xing(9):2950-2963. doi:10.1210/clinem/dgaa337
DOI: https://doi.org/10.30596/bf.v8i2.16295
DOI (PDF): https://doi.org/10.30596/bf.v8i2.16295.g9974
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: farmatera@umsu.ac.id
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.